Evoke Wealth LLC Sells 622 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Evoke Wealth LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 19,622 shares of the healthcare conglomerate’s stock after selling 622 shares during the period. Evoke Wealth LLC’s holdings in UnitedHealth Group were worth $9,926,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of UNH. Howard Capital Management Group LLC acquired a new position in UnitedHealth Group during the third quarter valued at approximately $341,000. Principal Financial Group Inc. lifted its holdings in UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock worth $1,039,933,000 after acquiring an additional 180,479 shares in the last quarter. Clarkston Capital Partners LLC bought a new stake in shares of UnitedHealth Group in the third quarter worth about $203,000. Prudent Man Advisors LLC lifted its holdings in shares of UnitedHealth Group by 28.5% during the 3rd quarter. Prudent Man Advisors LLC now owns 2,963 shares of the healthcare conglomerate’s stock valued at $1,732,000 after purchasing an additional 658 shares in the last quarter. Finally, Aljian Capital Management LLC raised its holdings in UnitedHealth Group by 14.2% during the 3rd quarter. Aljian Capital Management LLC now owns 16,243 shares of the healthcare conglomerate’s stock worth $9,497,000 after buying an additional 2,017 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of a number of analyst reports. Truist Financial decreased their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Wells Fargo & Company reduced their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Up 2.1 %

UNH stock opened at $499.01 on Tuesday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The firm has a market capitalization of $456.45 billion, a PE ratio of 32.19, a PEG ratio of 1.37 and a beta of 0.62. The stock has a 50-day simple moving average of $511.11 and a two-hundred day simple moving average of $549.15.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.83 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.68%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.